NEW YORK, NY / ACCESSWIRE / June 17, 2024 / Pomerantz LLP is investigating claims on behalf of investors of PetMed Express, Inc. ("PetMed" or the "Company") (NASDAQ:PETS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
PetMed Express, Inc. (NASDAQ:PETS ) Q4 2024 Earnings Conference Call June 11, 2024 4:30 PM ET Company Participants John Mills - Investor Relations, ICR Sandra Campos - Chief Executive Officer and President Christine Chambers - Chief Financial Officer Conference Call Participants Ryan Meyers - Lake Street Capital Markets Erin Wright - Morgan Stanley Operator Greetings and welcome to PetMed Express Fourth Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Pets at Home was one of the FTSE 250's best performers on Wednesday, as the retailer announced full-year results in line with January's downgraded guidance.
Pets at Home Group PLC (LSE:PETS) announced plans for new £25 million share buyback after what it said was a "foundational year" as sales growth slowed less than expected in the final quarter. Largely the preliminary results for the 52 weeks to 28 March were in line with pre-announced guidance from the pets-and-vets chain.
Pets at Home Group PLC (LSE:PETS) reports on Wednesday, 29 May, after scaling back profit guidance in March on squeezed consumer spending. Pre-tax profit guidance of £132 million was laid out in late March, against £136 million previously, as growth in its retail business was slower than expected in the third quarter.